Are you Dr. Piliang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273
Summary
- Dr. Melissa Piliang, MD is a board certified dermatologist in Cleveland, Ohio. She is currently licensed to practice medicine in Ohio, Florida, and Indiana. She is affiliated with Cleveland Clinic, VA Northeast Ohio Healthcare System, and Cleveland Clinic Lutheran Hospital.
Education & Training
Cleveland Clinic FoundationFellowship, Dermatopathology, 2005 - 2006- Cleveland Clinic FoundationResidency, Dermatology, 2001 - 2005
Indiana University School of MedicineClass of 2001
Certifications & Licensure
OH State Medical License 2001 - 2026
FL State Medical License 2015 - 2025
IN State Medical License 2008 - 2025- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysi...Melissa Piliang, Charles Lynde, Brett King, Paradi Mirmirani, Rodney Sinclair
Journal of the American Academy of Dermatology. 2025-02-01 - 1 citationsEfficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated an...Melissa Piliang, Jennifer Soung, Brett King, Jerry Shapiro, Lidia Rudnicka
The British Journal of Dermatology. 2025-01-24 - Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement.Yagiz Matthew Akiska, Paradi Mirmirani, Ingrid Roseborough, Erin Mathes, Tina Bhutani
JAMA Dermatology. 2025-01-01
Press Mentions
Responses Sustained with Ritlecitinib in Patients with Alopecia Through 48 WeeksOctober 22nd, 2024- Study Finds That Nail Salon UV Lamps Could Increase Cancer RiskJanuary 23rd, 2023
- Getting Your Nails Done Frequently Could Damage the DNA in Your HandsJanuary 19th, 2023
- Join now to see all
Professional Memberships
- Fellow
